Australia appears to be experience a groundbreaking therapy for weight issues: Retatrutide. This new dual compound – targeting on both GLP-1 and GIP receptors – demonstrates promising efficacy in clinical studies, suggesting considerable decreases in weight. While availability hasn't occurred with TGA, several Australians struggling weight-rela